Nephrogenic Systemic Fibrosis
📧 Sign up to get email alerts when something new happens for Nephrogenic Systemic Fibrosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2014-11-04Clinical Trial Update: Evaluation of the Risk of NSF Following MultiHance Injection in Patients With Chronic Kidney Disease
A completed clinical trial assessing the risk of nephrogenic systemic fibrosis after MultiHance (gadoteridol) administration in patients wit…
-
CLINICAL_TRIALS safety_alert · 2014-09-22Clinical Trial Update: Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist
A clinical trial update reports the risk of Nephrogenic Systemic Fibrosis in patients with moderate renal insufficiency following administra…
-
EMA safety_alert · 2007-02-07Public statement: Vasovist and nephrogenic systemic fibrosis (NSF)
EMA public statement regarding the contrast agent Vasovist and the risk of nephrogenic systemic fibrosis (NSF), highlighting safety conside…